Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
This grant opportunity invites applications to conduct phase 1 and phase 1b/2a clinical trials together, simplifying early-stage testing of new drug treatments for Alzheimer's and related dementias. These treatments, which can be small molecules or biologics, should target non-amyloid/non-tau mechanisms and aim to improve cognitive or neuropsychiatric symptoms in patients at various stages of …
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD)…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers